Ivermectin Stada

Ivermectin, the active ingredient in Ivermectin Stada, is an anthelmintic presented as an oral tablet for oral use. It treats infections caused by parasitic worms and ectoparasites, including river blindness, strongyloidiasis, lymphatic filariasis, scabies and head lice, and is prescribed for patients requiring parasite eradication.

GNH USA supplies Ivermectin Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company ensures quality manufacturing according to EU standards and provides reliable global distribution.

Ivermectin is used to treat a range of parasitic infections by targeting helminths and ectoparasites.

Onchocerciasis: reduces microfilarial load and helps prevent disease progression. Strongyloidiasis: eliminates intestinal larvae and prevents disseminated infection. Lymphatic filariasis: decreases adult worm burden and reduces transmission risk. Scabies: eradicates the Sarcoptes mite, relieving skin lesions. Pediculosis: kills head lice, controlling infestation.

Ivermectin may cause a variety of adverse reactions, ranging from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools, usually self‑limiting. - Dizziness: transient light‑headedness. - Pruritus: skin itching, often at the site of parasite death.

Serious or Rare Side Effects: - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Neurological events: seizures, encephalopathy, or altered consciousness. - Hepatotoxicity: elevated liver enzymes or hepatitis.

Before prescribing Ivermectin, clinicians should consider several safety measures.

Assess infection type: confirm parasitic diagnosis before use. Review concomitant medications: avoid drugs that affect central nervous system function. Monitor liver function: patients with hepatic impairment may need dose adjustment. Pregnancy and lactation: use only if benefits outweigh potential risks. Store at ambient temperature: keep in original container, protect from moisture and light.

Ivermectin can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors: ketoconazole, itraconazole – may increase ivermectin levels. - P‑glycoprotein inhibitors: verapamil – may raise systemic exposure.

Moderate Interactions (Monitor Closely): - Warfarin: may enhance anticoagulant effect. - Anticonvulsants: carbamazepine – may reduce ivermectin concentration. - Macrolide antibiotics: erythromycin – potential modest increase in exposure.